Deep learning reconstruction combined with contrast enhancement boost improves image quality of low-contrast-dose ctpa: a prospective randomized study.
Source check: Source checked. Not independent scientific confirmation.
Finding: In a 106-patient randomized CTPA study, deep-learning reconstruction and contrast-enhancement boost improved image quality under low contrast dose; their interaction increased CNR and the combined protocol scored highest on visibility. This is an imaging-quality result, not a patient-outcome benefit.
Technology: DLR reconstructs low-contrast-dose CTPA; CE-boost modifies contrast appearance
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
- AI contribution
- DLR reconstructs low-contrast-dose CTPA; CE-boost modifies contrast appearance.
- Test and result
- In a 106-patient randomized CTPA study, deep-learning reconstruction and contrast-enhancement boost improved image quality under low contrast dose; their interaction increased CNR and the combined protocol scored highest on visibility. This is an imaging-quality result, not a patient-outcome benefit. Evaluation: Prospective randomized two-arm trial with factorial reconstruction comparison and blinded quantitative/qualitative assessments.
- Limitation / still unknown
- The randomized study measured image quality; improved patient outcomes from the imaging protocol were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12880-026-02998-6
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.